CVS Health Corporation
95.38USD
-0.6900 (-0.72%)
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 322.5B | 357.8B | 372.8B | 402.1B | 417.6B | 429.3B |
| Q1 | 76.8B | 85.3B | 88.4B | 94.6B | 100.4B | — |
| Q2 | 80.6B | 88.9B | 91.2B | 98.9B | 106.1B | — |
| Q3 | 81.2B | 89.8B | 95.4B | 102.9B | 104.6B | — |
| Q4 | 83.8B* | 93.8B* | 97.7B* | 105.7B* | 107.0B | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 3.26 | 6.47 | 3.66 | 1.39 | 7.97 | 8.51 |
| Q1 | 1.77 | 1.65 | .880 | 1.41 | 2.30 | — |
| Q2 | 2.29 | 1.48 | 1.41 | .800 | 2.31 | — |
| Q3 | -2.59 | 1.75 | .070 | -3.13 | 1.62 | — |
| Q4 | 1.76* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
| 1.59* |
| 1.30* |
| 2.32* |
| 1.29 |
| — |